The results suggest the potential of semaglutide – the main ingredient in Ozempic and Novo’s higher-dose weight-loss drug ...
Q4 2024 Earnings Conference Call February 12, 2025 10:00 AM ETCompany ParticipantsWill McDowell - Vice President ...
Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...
Partnership taps real-world data to accelerate clinical trials, research, and drug development in Japan. CAMBRIDGE, Mass., Feb. 12, 2025 /PRNewswire/ -- TriNetX, a global leader in real-world ...
Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...